VCYT FY 2014 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$38M+74.5% YoY

Gross Profit

$22M56.5% margin

Operating Income

-$29M-76.0% margin

Net Income

-$29M-76.9% margin

EPS (Diluted)

$-1.36

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$30M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$65M

Total Liabilities

$23M

Stockholders' Equity

$41M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$22M	+74.5%
Gross Profit	$22M	$9M	+132.7%
Operating Income	-$29M	-$23M	-25.2%
Net Income	-$29M	-$26M	-14.8%